AstraZeneca pauses two lung cancer drug combination trials
October 09, 2015 at 07:54 AM EDT
LONDON, Oct 9 (Reuters) - AstraZeneca has temporarily halted two clinical trials combining experimental drugs to treat lung cancer, following reports of lung disease in some patients, the company said on Friday.
